med-congress

Medizinische Fortbildungen, Kongresse und E-Learning

Interactive e-Learning OncoCase 56: Management of adverse events during first-line treatment of locally advanced or metastatic urothelial carcinoma with enfortumab vedotin and pembrolizumab

Online-Kurs/E-Learning

Datum	21. 05. 2026, 09:00 - 31. 01. 2027, 19:00
Webcode	VCD3-6FX0
Fachrichtung	Medizinische Onkologie Radioonkologie Hämatologie
Referent/en	PD Dr. med. Alex Friedlaender
CME	SGMO 1
Sprache	Englisch
Zielgruppen	Spezialisten Spitalärzte/innen Assistenzärzte/innen
Programm	Interactive clinical e-learning case featuring a realistic, practice-based scenario, designed to deepen your medical expertise and support your professional development. CME accredited.
Sponsoren	Astellas Pharma AG AstraZeneca AG Daiichi Sankyo Pharma (Schweiz) AG Bayer (Schweiz) AG Bristol-Myers Squibb SA GlaxoSmithKline AG Immedica Pharma Germany GmbH Incyte Biosciences International Sàrl Johnson & Johnson Consumer Health Care Switzerland MSD Merck Sharp & Dohme AG Roche Pharma (Schweiz) AG Sandoz Pharmaceuticals AG
Veranstaltungsort	Online Veranstaltung
Veranstalter / Information / Anmeldung	just-medical!
Anmeldeformular

Datum 21. 05. 2026, 09:00 - 31. 01. 2027, 19:00
Webcode VCD3-6FX0
Fachrichtung Medizinische Onkologie Radioonkologie Hämatologie
Referent/en PD Dr. med. Alex Friedlaender
CME SGMO 1
Sprache Englisch
Spezialisten Spitalärzte/innen Assistenzärzte/innen
Interactive clinical e-learning case featuring a realistic, practice-based scenario, designed to deepen your medical expertise and support your professional development. CME accredited.
Astellas Pharma AG AstraZeneca AG Daiichi Sankyo Pharma (Schweiz) AG Bayer (Schweiz) AG Bristol-Myers Squibb SA GlaxoSmithKline AG Immedica Pharma Germany GmbH Incyte Biosciences International Sàrl Johnson & Johnson Consumer Health Care Switzerland MSD Merck Sharp & Dohme AG Roche Pharma (Schweiz) AG Sandoz Pharmaceuticals AG
Veranstaltungsort Online Veranstaltung
just-medical!

Nicht verpassen

Hier finden Sie Ihre medizinische Fortbildung weltweit, Ihren nationalen oder internationalen Ärztekongress sowie medizinische E-Learning-Plattformen und praktische Fortbildungskurse.

Interactive e-Learning OncoCase 56: Management of adverse events during first-line treatment of locally advanced or metastatic urothelial carcinoma with enfortumab vedotin and pembrolizumab

Hämatologie Medizinische Onkologie Radioonkologie

Online

21. 05. 2026 09.00 to 31. 01. 2027 19.00

med-congress

Interactive e-Learning OncoCase 56: Management of adverse events during first-line treatment of locally advanced or metastatic urothelial carcinoma with enfortumab vedotin and pembrolizumab

Zielgruppen

Programm

Sponsoren

Veranstalter / Information / Anmeldung

Anmeldeformular

Nicht verpassen

Interactive e-Learning OncoCase 56: Management of adverse events during first-line treatment of locally advanced or metastatic urothelial carcinoma with enfortumab vedotin and pembrolizumab